Historie von Umsatz, Gewinn und Cashflow aus den offiziellen Geschäftsberichten.
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. Its Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States.
Interaktive Charts und vollständige Abschlüsse ansehen → Bewertungsmodell (DCF) →
| Gewinn- und Verlustrechnung | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gesamtumsatz | $18.2B | $17.4B | $19.1B | $18.8B | $19.2B | $22.1B | $22.1B | $22.3B | $21.8B | $21.7B | $22.6B | $20.9B | $22.7B | $23.9B | $25.4B | $22.2B | $20.7B | $18.3B | $16.6B | $15.4B | $14.6B |
| Bruttoergebnis | — | $6.8B | $6.8B | $18.8B | $19.2B | $22.1B | $22.1B | $22.3B | $21.8B | $21.7B | $22.6B | $20.9B | $22.7B | $23.9B | $25.4B | $22.2B | $20.7B | $18.2B | $16.6B | $15.4B | $14.6B |
| Bruttomarge % | — | 38.9% | 35.6% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 99.6% | 100.0% | 100.0% | 100.0% |
| Betriebsergebnis (EBIT) | — | $4.6B | $6.4B | $5.3B | $4.9B | $5.3B | $4.2B | $4.4B | $4.2B | $4.3B | $4.3B | $4.2B | $4.8B | $5.1B | $4.6B | $3.2B | $3.7B | $2.3B | $1.9B | $2.5B | $2.3B |
| Operative Marge % | — | 26.6% | 33.6% | 27.9% | 25.4% | 24.1% | 18.8% | 19.9% | 19.3% | 19.7% | 19.2% | 19.9% | 21.1% | 21.3% | 18.0% | 14.4% | 18.0% | 12.6% | 11.6% | 16.4% | 15.6% |
| Jahresüberschuss | $4.9B | $3.6B | $5.4B | $4.7B | $4.4B | $4.3B | $4.8B | $3.3B | $2.9B | $4.4B | $2.7B | $2.5B | $3.0B | $3.2B | $2.9B | $2.0B | $2.3B | $1.5B | $1.3B | $1.6B | $1.5B |
| Nettomarge % | 26.7% | 20.9% | 28.5% | 24.7% | 23.1% | 19.6% | 21.6% | 14.8% | 13.4% | 20.2% | 11.8% | 12.1% | 13.0% | 13.2% | 11.3% | 8.9% | 11.3% | 8.2% | 7.6% | 10.6% | 10.2% |
| EBITDA | — | $5.5B | $6.4B | $5.3B | $4.9B | $6.5B | $5.4B | $4.4B | $4.2B | $4.3B | $4.3B | $4.2B | $4.8B | $5.1B | $4.6B | $3.2B | $3.7B | $2.3B | $2.0B | $2.5B | $2.3B |
| Ergebnis je Aktie (EPS) | $9.28 | $6.85 | $9.63 | $7.78 | $6.93 | $6.39 | $6.67 | $4.43 | $3.77 | $5.48 | $3.21 | $2.92 | $3.25 | $3.38 | $3.05 | $2.09 | $2.48 | $1.60 | $1.31 | $1.65 | $1.48 |
| Ausstehende Aktien (Mio.) | — | 532M | 565M | 599M | 638M | 677M | 716M | 746M | 775M | 798M | 828M | 866M | 908M | 935M | 939M | 939M | 946M | 938M | 958M | 988M | 1,004M |
Quelle: veröffentlichte Unternehmensberichte (SEC). Bitte prüfen Sie die Zahlen vor Verwendung auf SEC EDGAR.
Bilanzen, Cashflow-Rechnungen, Quartalsdaten und alle Kennzahlen finden Sie im interaktiven Viewer für AFL. /companies/us/AFL
Die Informationen auf dieser Website dienen ausschließlich Bildungs- und Informationszwecken und stellen keine Anlageberatung dar. Es werden keine Kursziele und keine Anlageurteile veröffentlicht.
About TickerBase · Data methodology & sources · Privacy · Terms